SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-007037
Filing Date
2022-02-11
Accepted
2022-02-11 17:00:23
Documents
12
Period of Report
2022-02-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea155449-8k_aikido.htm   iXBRL 8-K 23197
  Complete submission text file 0001213900-22-007037.txt   194234

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aiki-20220208.xsd EX-101.SCH 3045
3 XBRL LABEL FILE aiki-20220208_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE aiki-20220208_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT ea155449-8k_aikido_htm.xml XML 3504
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 22622360
SIC: 8731 Services-Commercial Physical & Biological Research